Mergers and Acquisitions
A Cypress/Infineon Deal Rejection Could Have Broader Chip M&A Repercussions
Should U.S. regulators block the Cypress/Infineon deal on national security grounds, China could respond by blocking M&A transactions involving U.S. acquirers.
Nokia and its Peers Have Good Reasons to Explore M&A
With telecom capex still under pressure amid 5G rollout delays, equipment suppliers might find consolidation to be the best path to profit growth.
If You Invest in Small-Cap Stocks, You've Got to Learn to Deal With Setbacks
Tivity Health's big price drop serves as an example of the thought process an investor must go through when a holding takes an unexpected hit.
Morgan Stanley Jumps Into the Deep End With E*Trade Purchase
What I suspect is that the stock price of MS will likely trade in a relatively tight range.
There Are No Signs That the Mood of the Market Has Shifted
The pockets of strong trading action in individual stocks illustrates an appetite for speculative action.
Here's an Options Trade Idea for Sprint
If one is long the stock, it's time for a victory lap for hanging on for so long.
Sprint Shares Sprint Higher to Shake Up Its Charts
A federal judge rules in favor of Sprint's merger with T-Mobile US and sends Sprint's stock climbing, but it will take time to see where it settles out.
Jim Cramer: Why Simon Property's Taubman Centers Buy Is So Important
This is a statement buy that is changing the shopping mall narrative, and we need to see one in oil and gas next.
YUM! Has The Habit, Are There More Acquisitions Coming?
If YUM wanted to go big in casual dining, it could make a play for Dine Brands Global.
Odds Favor Penn National Trading Higher Based on Its Charts
The casino operator's shares just received a boost from a deal in which the company is taking a large stake in Barstool Sports.
Restaurant Acquisition Trend Should Remain on Wall Street's Menu
The deals that has been taking place in the industry in the last few years are likely to continue.
United Technologies Should Resume Its Advance When the Broad Market Stabilizes
Let's review the charts and indicators.
Biotech's Big Week Finds a Big Winner in Adaptimmune
The clinical stage company sees its shares climb after announcing some significant news during this week's J.P. Morgan Healthcare Conference.
What If Fitbit's Deal With Alphabet Doesn't Happen?
It's likely the deal goes through, but I don't believe that attempting to take advantage of FIT's current 11% discount is worth the risk.
2 Potential Targets as Biotech Acquisition Activity Heats Up
TG Therapeutics and Exelixis could find themselves on the shopping lists of other companies.
Making Sausage: How the Fitbit Deal Got Done
A document filed with the SEC reveals the behind-the-scenes competition between Alphabet and another suitor for the hand of the smartwatch maker.
Big Merger Monday Conjures Up Thoughts of Potential Biotech Targets
The planned acquisition of The Medicines Company by Novartis spurs prospects of other deals in the drug business.
IAC's CFO Talks About Holding Onto ANGI and the Current M&A Environment
During a talk with TheStreet, CFO Glenn Schiffman talked about IAC's reasons for holding off on an ANGI Homeservices spinoff, as well as the differences between private and public valuations.
Foot Locker's Assets May Look Better Than Its Charts
Let's see whether FL is a good fit for investors right now.
Jim Cramer: Think Stocks Are Too Pricey? These Big Takeovers Prove They're Not
We're seeing lots of companies snapping up their peers, and the market is applauding.
'Dance' With E*Trade as It Searches for a Partner
With the potential TD Ameritrade deal, clearly E*Trade will not be 'talking to Chuck.'
News While You Slept, Semi Tough and Updates on Amgen and Splunk: Market Recon
Also, Fed Chairman Powell says there are no plans for a U.S. digital currency (for now), plus Tesla's electric pickup.
HP and Xerox? Not Such a Bad Idea
With Carl Icahn involved on both sides, we can expect him to lean heavily on both Boards to come to an agreement.
HP Has My Attention, but I'm Not Getting In Now
If tempted, don't forget HPQ will report the firm's fourth quarter performance next Tuesday.
HP Plays Hard to Get, but Charts Provide a Clearer Picture
HP's board of directors has rejected Xerox's takeover bid, but the door has not been closed on a potential combination.
Viacom's Charts Can't Divine Impact on Price Action of CBS Merger
Traders would do well to find another stock to trade right now.
I Still Like Housing, Just Not as Much as Before
After the strong run of homebuilders in 2019, the sector simply isn't as oversold as it was to start the year.
Trade Walgreens for the Same Reason It Might Go Private
I see upside back to above $70 regardless of whether the company gets taken private.
CBS Earnings Lead to 'Interesting' Questions - And What About the Stock?
Things that make you go hmmm ahead of the Viacom merger.
CBS Charts Eye a Potential Rise in Its Shares
The media giant's technical signals hint at an upside move in its stock.